Two therapies can be better than one for treating some cancers, concludes a Yale study published Oct. 22 in JCI Insight that ...
New Scientist on MSN
mRNA covid vaccines spark immune response that may aid cancer survival
An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...
The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.
Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.
COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are ...
A study published in Nature looks at COVID-19 mRNA vaccines and the immune response to tumours during immunotherapy. Prof Andrew Beggs, MRC Senior Clinical Fellow and Consultant Colorectal Surgeon, ...
OncoNano Medicine, Inc. ("OncoNano") announced encouraging first-in-human results from Part 1 of its Phase 1 ON-5001 trial ...
Background:Respiratory viruses, including influenza viruses, respiratory syncytial virus (RSV), coronaviruses, and other emerging zoonotic pathogens, remain ...
The preclinical drug from Vanqua Bio is designed to inhibit “C5aR1,” a part of the immune system that regulates inflammation.
STAT Wunderkind Sydney Ramirez is revealing the immune system in our nasal passages and working toward better disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback